Vanguard Group Inc Mannkind Corp Transaction History

Vanguard Group Inc

$6.57 Trillion
Q4 2025

A detailed history of Vanguard Group Inc transactions in Mannkind Corp stock. As of the latest transaction made, Vanguard Group Inc holds 17,880,873 shares of MNKD stock, worth $90.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,880,873

Previous 17,630,583 1.42%

Holding current value

$90.5 Million

Previous $94.7 Million 4.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 29, 2026	BUY	$4.88 - $6.06 $1.22 Million - $1.52 Million	250,290 Added 1.42%	17,880,873 $90.5 Million
Q3 2025 Nov 07, 2025	SELL	$3.42 - $5.74 $1.81 Million - $3.04 Million	-530,280 Reduced 2.92%	17,630,583 $94.7 Million
Q2 2025 Aug 11, 2025	BUY	$3.71 - $5.04 $3.11 Million - $4.23 Million	838,684 Added 4.84%	18,160,863 $67.9 Million
Q1 2025 May 09, 2025	BUY	$4.92 - $6.6 $6.22 Million - $8.34 Million	1,263,622 Added 7.87%	17,322,179 $87.1 Million
Q4 2024 Feb 11, 2025	BUY	$5.93 - $7.44 $2.49 Million - $3.13 Million	420,334 Added 2.69%	16,058,557 $103 Million

Q3 2024 Nov 13, 2024	BUY	$5.01 - $6.7 $1.04 Million - $1.39 Million	207,342 Added 1.34%	15,638,223 $98.2 Million
Q2 2024 Aug 13, 2024	BUY	$4.05 - $5.43 $1.18 Million - $1.58 Million	290,172 Added 1.92%	15,430,881 $80.5 Million
Q1 2024 May 10, 2024	SELL	$3.25 - $5.27 $350,671 - $568,627	-107,899 Reduced 0.71%	15,140,709 $68.6 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $2 Million - $2.57 Million	598,895 Added 4.09%	15,248,608 $55.5 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $39,713 - $55,355	10,157 Added 0.07%	14,649,713 $60.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $2.41 Million - $3.11 Million	648,548 Added 4.64%	14,639,556 $59.6 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $1.29 Million - $1.84 Million	326,780 Added 2.39%	13,991,008 $57.4 Million
Q4 2022 Feb 10, 2023	BUY	$3.02 - $5.37 $1.67 Million - $2.97 Million	553,919 Added 4.23%	13,664,228 $72 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $824,961 - $1.2 Million	275,907 Added 2.15%	13,110,309 $40.5 Million
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $139,379 - $249,003	52,202 Added 0.41%	12,834,402 $48.9 Million
Q1 2022 May 13, 2022	BUY	$2.62 - $4.45 $357,960 - $607,985	136,626 Added 1.08%	12,782,200 $47 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $2.69 Million - $3.56 Million	663,829 Added 5.54%	12,645,574 $55.3 Million
Q3 2021 Nov 12, 2021	SELL	$3.89 - $5.48 $3.56 Million - $5.01 Million	-913,908 Reduced 7.09%	11,981,745 $52.1 Million
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.45 $46.6 Million - $70.3 Million	12,895,653 New	12,895,653 $70.3 Million

Others Institutions Holding MNKD

# of Institutions

260

Shares Held

165M

Call Options Held

2.76M

Put Options Held

689K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.3B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Mannkind Corp Transaction History